Understanding calcium channel gene disorders and developing new therapies
Demystifying Disorders of Bicistronic Calcium Channel Genes
This study is looking at how changes in certain genes related to calcium channels can affect health, especially for people with serious calcium channel disorders, and it aims to find new ways to help them by exploring how these genes and their proteins work in human nerve cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11082256 on NIH RePORTER |
What this research studies
This research investigates the complex relationships between genetic mutations in calcium channel genes and the resulting health conditions. It focuses on three specific bicistronic calcium channel genes that produce both calcium channel proteins and a newly identified transcription factor. By studying how these proteins function and how mutations affect cellular processes, the research aims to uncover new therapeutic strategies for patients with severe calcium channel disorders. The approach includes using advanced techniques with human neurons to better understand the underlying biology of these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with severe calcium channel gene disorders or those with related neurological issues.
Not a fit: Patients with calcium channel disorders that do not involve the specific genes being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients suffering from severe calcium channel gene disorders.
How similar studies have performed: Other research has shown promise in understanding calcium channel disorders, but this specific approach to bicistronic genes is relatively novel.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Gomez, Christopher Manuel — University of Chicago
- Study coordinator: Gomez, Christopher Manuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.